| | |
|---|
|
|
|
High Content Image Analysis using a Laser Scanning Microplate Cytometer
TTP Labtech
Microscope-based high-content instruments offer high optical resolution, however, the limited field of view afforded by their objective lenses can mean lengthy read times for some assays, especially where multiple image capture per well is required. Wherever possible, only a small percentage of the total number of cells present in a test well are analysed to keep plate read times at a minimum, which may not always be ideal. Microplate laser- scanning cytometers, such as TTP LabTech’s Acumen® eX3
|
Stem Cell Derived Human Neurons in CNS Drug Discovery
Scottish Biomedical
Central nervous system disorders affect many people worldwide. To increase the quality and number of drugs available for treatments of CNS disorders such as Alzheimer’s, schizophrenia and anxiety, the success rate of CNS drug discovery programmes must be improved. The challenge in drug discovery is to develop more relevant assay systems to identify lead compounds for further development. Cell based screening assays currently used for CNS drug development involve primary cells or commercially
|
| |
|
|
Drug Discovery & Development of Innovative Therapeutics, Boston, MA, USA
04 August 2008 - 07 August 2008
Practical, Actionable Ideas for Accelerating Discovery and Early Development. The Drug Discovery & Development of Innovative Therapeutics (DDT) World Congress is the ONLY international event that compares applications of translational medicine and transforming technologies across multiple therapeutic areas to help you find new ways to achieve POC quickly. View the full program agenda online at www.drugdisc.com.
|
Stem Cells Europe, Amsterdam, The Netherlands
01 September 2008 - 03 September 2008
Select Biosciences inaugural Stem Cells Europe Conference and Exhibition. Confirmed Speakers include Stephen Minger of Kings College, Bernard Siegel of Genetics Policy Institute and Fergus McKenzie of ITI Life Sciences.
|
The European Congress on Anti-Aging and Aesthetic Medicine, Düsseldorf, Germany
11 September 2008 - 14 September 2008
The European Congress on Anti-Aging and Aesthetic Medicine (ECAAAM) will take place on 11-14 September in Düsseldorf, Germany. We invite you to join this fast growing medical specialty and network with the most influential educators and industrialists from around the world.
|
|
|
|
|
|
|
Cancer Stem Cells - Emerging Therapeutic, Diagnostic and Market Opportunities
Published April 2007
The last decade has seen the emergence of a new paradigm in the therapeutic strategies which may be available to target cancer. This is based on the existence of so called Cancer Stem Cells (CSCs), found in small populations within the bulk of normal proliferating cancer cells, in tumours. Many scientists believe that CSCs are responsible for the development and spread of cancer and explain why the disease is resistant to many conventional treatments and able to reestablish itself after therapy.
|
Tissue Engineering & Stem Cell Technology Report 2007
Published Febraury 2007
The market potential of this technology is so huge that revenues may be in excess of $10 billion by 2013. This is a market that you should be part of - NOW!! With a complex regulatory structure still to overcome, yet continued high level investment, many of your competitors are aware of the the commercial opportunities within Tissue Engineering & Stem Cell Technology.
|
|
| |
|